Laboratory signs detected in six cases of JAK2+MPN, NOS with available data occurring after CML were as follows: PTL increase in 4/6 cases (26, 38, 39); WBC increase in 3/6 (19, 22) and LDH increase in 1/6 (26). This evidence concerns the gene JAK2 and myeloproliferative disorder.